文献速递药物不良反应与药物警戒

类风湿关节炎患者甲氨蝶呤致肝损伤的全基因组关联研究

Genome-wide Association Study of Methotrexate-Induced Liver Injury in Rheumatoid Arthritis Patients.
PubMed 文献 · Clin Pharmacol Ther · 2023-02-20

该研究通过嵌套病例对照全基因组关联分析,探索类风湿关节炎患者甲氨蝶呤致药物性肝损伤的遗传风险因素,共纳入108例MTX-DILI病例和311例对照。未发现与MTX-DILI显著相关的SNP,但发现7个提示性变异(P值7.43×10⁻⁸至4.86×10⁻⁶),其中5个位于FTCDNL1、BCOR、FGF14、RBMS3和PFDN4/DOK5的内含子蛋白编码区。

要点

  • 未发现与MTX-DILI达到全基因组显著性的遗传变异。
  • 7个提示性SNP需进一步验证,5个位于FTCDNL1等基因内含子区。
  • 候选基因SPATA9、PLCG2、JAK1、MTHFR C677T等均无显著关联。

核心结论

  • 未发现与甲氨蝶呤致肝损伤显著相关的遗传变异,但提示性SNP需进一步研究。

研究设计与样本

  • 嵌套病例对照全基因组关联研究,7个国际研究组提供类风湿关节炎使用MTX患者的血样和数据。
  • MTX-DILI定义为ALT至少3倍正常上限,对照ALT未超过2倍正常上限。
  • 按研究 site 以3:1匹配年龄、性别和MTX使用时长,共纳入108例MTX-DILI和311例对照。
  • 使用Illumina GSA MD-24v1-0芯片基因分型,基于1000 Genomes参考面板填充,加性模型校正性别、国家和年龄。

主要发现

  • 全基因组显著性阈值P≤5×10⁻⁸,提示性阈值P≤5×10⁻⁶。
  • 未发现SNP达到显著关联,发现7个提示性变异P值7.43×10⁻⁸至4.86×10⁻⁶。
  • 5个提示性SNP位于FTCDNL1、BCOR、FGF14、RBMS3和PFDN4/DOK5的内含子蛋白编码区。
  • 候选SPATA9 rs72783407、PLCG2 rs60427389、RAVER2 rs72675408、JAK1 rs72675451、PTPN2 rs2476601、MTHFR C677T rs1801133及HLA区域未见显著发现。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Hepatotoxicity is a serious adverse drug reaction related to methotrexate (MTX). However, the cause of drug-induced liver injury (DILI) is still unclear and unpredictable. Genetic risk factors may predispose for MTX-DILI. Therefore, we conducted a nested case-control genome-wide association study to explore genetic risk factors associated with MTX-DILI. Seven international groups contributed blood samples and data of patients with rheumatoid arthritis who used MTX. MTX-DILI was defined as an alanine aminotransferase (ALT) level of at least three times the upper limit of normal (ULN), to increase contrast controls ALT levels did not raise above two times the ULN. Per study site, control subjects and patients with MTX-DILI (ratio 3:1) were matched for age, gender, and duration of MTX use. Patients were genotyped using Illumina GSA MD-24v1-0 and data were imputed using the 1000 Genomes reference panel. Single-nucleotide polymorphisms (SNPs) were analyzed using an additive genetic model, corrected for sex, country, and age. A P-value of ≤ 5 × 10-8 was considered significant, whereas a P-value of ≤ 5 × 10-6 was considered suggestive. A total of 108 MTX-DILI cases and 311 controls were included for association analysis. None of the SNPs were significantly associated with MTX-DILI. However, we found seven suggestive genetic variants associated with MTX-DILI (P-values 7.43 × 10-8 to 4.86 × 10-6 ). Of those, five SNPs were in the intronic protein-coding regions of FTCDNL1, BCOR, FGF14, RBMS3, and PFDN4/DOK5. Investigation of candidates SPATA9 (rs72783407), PLCG2 (rs60427389), RAVER2 (rs72675408), JAK1 (rs72675451), PTPN2 (rs2476601), MTHFR C677T (rs1801133), and into the HLA region did not show significant findings. No genetic variants associated with MTX-DILI were found, whereas suggestive SNPs need further investigation.

来源:Clin Pharmacol Ther,查看原文。版权归原作者所有。

引用

  1. Eektimmerman F, Swen JJ, den Broeder AA, et al. Genome-wide Association Study of Methotrexate-Induced Liver Injury in Rheumatoid Arthritis Patients. Clin Pharmacol Ther. 2023. PMID: 36708065. doi:10.1002/cpt.2858

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。